# Open Label Study to Assess the Efficacy and Safety of AKB-9778 in Subjects With Macular Edema Due to RVO

> **NCT02387788** · PHASE2 · COMPLETED · sponsor: **Aerpio Therapeutics** · enrollment: 16 (actual)

## Conditions studied

- Retinal Vein Occlusion

## Interventions

- **DRUG:** AKB-9778

## Key facts

- **NCT ID:** NCT02387788
- **Lead sponsor:** Aerpio Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2017-04
- **Final completion:** 2017-04
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2018-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02387788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02387788, "Open Label Study to Assess the Efficacy and Safety of AKB-9778 in Subjects With Macular Edema Due to RVO". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02387788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*